Cardinal Health, Inc. (CAH)

Market Cap	35.69B
Revenue (ttm)	222.58B
Net Income (ttm)	1.56B
Shares Out	238.79M
EPS (ttm)	6.45
PE Ratio	23.17
Forward PE	15.84
Dividend	$2.04 (1.37%)
Ex-Dividend Date	Oct 1, 2025

Volume	2,362,223
Open	150.40
Previous Close	150.56
Day's Range	146.71 - 151.31
52-Week Range	106.54 - 168.44
Beta	0.74
Analysts	Buy
Price Target	159.00 (+6.38%)
Earnings Date	Oct 31, 2025

About CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products....

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1979
• Employees: 57,700
• Stock Exchange: NYSE
• Ticker Symbol: CAH
• Website: https://www.cardinalhealth.com

Financial Performance

In 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.

Analyst Summary

According to 15 analysts, the average rating for CAH stock is "Buy." The 12-month stock price target is $159.0, which is an increase of 6.38% from the latest price.

Price Target

$159.0

(6.38% upside)

Analyst Consensus: Buy